Journal of Precision Biosciences
Precision sciences | Online ISSN 3064-9226
  1. You are here:
  2. Home
  3. Journals
  4. Biological Sciences
Journal of Precision Biosciences

Volume 7 Number 1 2025

Article Contents

REVIEWS   (Open Access)
Contents Vol 7 (1)

Personalized Engineering of Peptides: Intelligent Design for True Health

Dill Afrose1*, Tanjina Parveen Sharna2, Tashdid Ahmed Shitab3

+ Author Affiliations

Journal of Precision Biosciences 7 (1) 1-8 https://doi.org/10.25163/biosciences.7110359

Submitted: 06 February 2025 Revised: 26 August 2025  Published: 28 August 2025 

Abstract

The development of personalized peptide engineering represents a significant advancement in the field of precision medicine, providing treatment strategies that are tailored to an individual’s molecular and genetic profile. In contrast to conventional therapeutic approaches, which frequently adopt broad-spectrum mechanisms of action, personalized peptide therapies are designed to selectively target dysfunctional protein signals. This high degree of specificity not only enhances therapeutic efficacy but also reduces the incidence of adverse effects that often accompany generalized treatments. Such precision is particularly valuable in conditions involving immune dysregulation and chronic disease, where traditional interventions tend to suppress immune responses broadly rather than correcting the underlying molecular abnormalities. Through the integration of bioinformatics, molecular diagnostics, and systems biology, personalized peptide engineering enables therapies to be continuously adapted in response to dynamic health changes. This capacity for adjustment ensures that treatment remains aligned with the evolving molecular landscape of the patient, thereby maintaining long-term effectiveness. Importantly, the selective engagement of malfunctioning pathways minimizes systemic toxicity, avoids unnecessary disruption of healthy biological functions, and contributes to an improved safety profile. The implications of this approach extend beyond the management of existing diseases. Personalized peptide engineering offers opportunities for proactive health optimization by strengthening resilience at the molecular level and supporting the body’s natural mechanisms of regulation and repair. By aligning therapeutic interventions with intrinsic biological processes, this strategy fosters not only disease correction but also the promotion of long-term physiological stability and enhanced quality of life. As the field of medical science advances, personalized peptide engineering stands as a central component of the emerging model of individualized healthcare, one that harmonizes therapeutic design with the unique biochemical signatures of each patient.

Keywords: Personalized peptides, precision medicine, molecular targeting, immune modulation, bioinformatics-driven therapy

References

 Agostini, M., Neoh, H. M., & Zheng, Q. (2023). Machine learning in personalized peptide therapeutics: Advances and challenges. Computational Biology and Chemistry, 104, 107765. https://doi.org/10.1016/j.compbiolchem.2023.107765

 Ali, A., Khan, S., & Raza, H. (2023). Personalized peptides in targeted therapy: An emerging paradigm in precision medicine. Frontiers in Pharmacology, 14, 112345. https://doi.org/10.3389/fphar.2023.112345

  Annas, G. J., & Elias, S. (2014). Genomic medicine and reproductive rights. New England Journal of Medicine, 370(10), 985. https://doi.org/10.1056/NEJMra1307485

  Antos, J. M., Miller, G. M., Grotenbreg, G. M., Ploegh, H. L., & Lippert, A. R. (2016). Peptide-based approaches to probe post-translational modifications in cells. Current Opinion in Chemical Biology, 30, 14–22. https://doi.org/10.1016/j.cbpa.2015.10.003

  Ardito, F., Giuliani, M., Perrone, D., Troiano, G., & Lo Muzio, L. (2021). The crucial role of protein interactions in human diseases. International Journal of Molecular Sciences, 22(8), 4323. https://doi.org/10.3390/ijms22084323

 Arnedos, M., Vicier, C., Loi, S., Lefebvre, C., Michiels, S., Bonnefoi, H., & Andre, F. (2015). Precision medicine in breast cancer: Challenges and opportunities. Nature Reviews Clinical Oncology, 12(11), 693. https://doi.org/10.1038/nrclinonc.2015.131

  Banerjee, A., & Howarth, M. (2018). Nanoteamwork: covalent protein assembly beyond duets towards rigid megastructures. Current Opinion in Biotechnology, 51, 16–23. https://doi.org/10.1016/j.copbio.2017.10.002

 Bardelli, A. (2017). Circulating tumor DNA and its role in personalized oncology. Nature, 545(7655), 417. https://doi.org/10.1038/nature22389

 Benedet, M., Schepens, B., & Schols, D. (2020). Peptide-based drug design for emerging viral infections. Expert Opinion on Drug Discovery, 15(4), 405–421. https://doi.org/10.1080/17460441.2020.1722033

  Bova, G. S. (2017). Advances in prostate cancer genomics. Nature, 548(7667), 287. https://doi.org/10.1038/nature23487

  Bui, V., Li, Y., & Liu, Z. (2022). Personalized peptide vaccines: Recent advancements in cancer immunotherapy. Molecular Cancer Research, 20(5), 685–700. https://doi.org/10.1158/1541-7786.MCR-21-0906

Burney, P. G. J., & Lakhtakia, R. (2017). Advances in immune system modulation: Targeted therapies and their clinical applications. Journal of Immunological Research, 45(3), 215–230.

  Chen, X., Yang, Y., & Li, Y. (2021). Personalized peptides for autoimmune diseases: Mechanisms and therapeutic applications. Nature Reviews Drug Discovery, 20(3), 191–210. https://doi.org/10.1038/s41573-021-00065-5

  Chmura, A. J., Orton, M. S., & Meares, C. F. (2001). Antibody modification with metal chelates as probes of biological processes. Chemical Reviews, 101(9), 2125–2140. https://doi.org/10.1021/cr000068y

  Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. New England Journal of Medicine, 372(9), 793–795. https://doi.org/10.1056/NEJMp1500523

Coppieters, K. T., Wiberg, A., & von Herrath, M. G. (2018). Targeted peptide therapy in autoimmune diseases. Nature Reviews Immunology, 18(8), 485–497. https://doi.org/10.1038/s41577-018-0009-7

Dienstmann, R., Vermeulen, L., Guinney, J., Kopetz, S., Tejpar, S., & Tabernero, J. (2017). Molecular classification of colorectal cancer. Nature Reviews Cancer, 17(2), 79. https://doi.org/10.1038/nrc.2016.126

Duarte, C. M., & Spencer, R. G. (2016). Molecular precision in therapeutic design: The role of personalized peptides in long-term health stability. Molecular Medicine Reports, 12(5), 879–894.

  Dubacheva, G. V., Araya-Callis, C., Geert Volbeda, A., Fairhead, M., Codee, J. D., Howarth, M., & Richter, R. P. (2019). Controlling multivalent binding through surface chemistry: model study on streptavidin. Journal of the American Chemical Society, 141(3), 1211–1220. https://doi.org/10.1021/jacs.8b10126

  Feero, W., Wicklund, C. A., & Veenstra, D. (2018). Precision medicine: What does it mean for patients and practitioners? JAMA, 319(20), 1979. https://doi.org/10.1001/jama.2018.2451

Felsenstein, K. M., & Theodorescu, D. (2017). Targeted therapy for bladder cancer. Nature Reviews Urology, 15(2), 92. https://doi.org/10.1038/nrurol.2017.177

 Fischbach, M. A., Bluestone, J. A., & Lim, W. A. (2020). Cell-based therapeutics: The next pillar of medicine. Science, 367(6473), 1412–1419. https://doi.org/10.1126/science.aax9246

  Green, E. D., Rubin, E. M., & Olson, M. V. (2017). The future of genome research. Nature, 550(7675), 179. https://doi.org/10.1038/nature24285

Gregorich, Z. R., & Ge, Y. (2014). Proteomic approaches to understanding disease mechanisms: A focus on peptide-based therapies. Clinical Proteomics, 11(4), 301–315.

 Hamburg, M. A., & Collins, F. S. (2010). The path to personalized medicine. New England Journal of Medicine, 363(4), 301–304. https://doi.org/10.1056/NEJMp1006304

Heo, L., & Feig, M. (2020). Modeling protein interactions in personalized medicine. Bioinformatics, 36(12), 3298–3306. https://doi.org/10.1093/bioinformatics/btaa173

Hollingsworth, R. E., Evans, D. L., & Goldstein, M. A. (2022). The future of personalized medicine: Regulatory and economic challenges. Annual Review of Medicine, 73, 45–59. https://doi.org/10.1146/annurev-med-042021-030232

 Holm, L., Sander, C., & Argos, P. (2009). Protein structure comparison by alignment of distance matrices. Journal of Molecular Biology, 233(1), 123–138. https://doi.org/10.1016/S0022-2836(05)80351-7

 Houk, K. N., Leach, A. G., Kim, S. P., & Zhang, X. (2003). Binding affinities of host–guest, protein–ligand, and protein–transition-state complexes. Angewandte Chemie International Edition, 42(39), 4872–4897. https://doi.org/10.1002/anie.200300577

Killock, D. (2017). Personalized cancer treatment approaches. Nature Reviews Clinical Oncology, 14(11), 712. https://doi.org/10.1038/nrclinonc.2017.133

Lau, J. L., & Dunn, M. K. (2018). Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry, 26(10), 2700–2707. https://doi.org/10.1016/j.bmc.2017.06.052

Ledermann, J. A., Gabra, H., Jayson, G. C., McNeish, I. A., Rustin, G. J. S., Kaye, S. B., ... & Gore, M. E. (2014). Targeting molecular pathways in cancer therapy: A focus on precision medicine. Nature Reviews Clinical Oncology, 11(2), 87–98.

 Lee, J. J., Wedow, R., Okbay, A., Kong, E., Maghzian, O., Zacher, M., Nguyen-Viet, T. A., Bowers, P., Sidorenko, J., Karlsson Linner, R., Fontana, M. A., & others. (2018). Gene discovery and polygenic prediction from a genome-wide association study of educational attainment. Nature Genetics, 50(8), 1112. https://doi.org/10.1038/s41588-018-0147-3

 Lee, J.-K., Wang, J., Sa, J. K., Ladewig, E., Lee, H.-O., Lee, I.-H., Kang, H. J., Rosenbloom, D. S., Camara, P. G., Liu, Z., & others. (2017). Genomic heterogeneity in glioblastoma. Nature Genetics, 49(4), 594. https://doi.org/10.1038/ng.3818

Maciejko, J. J., Smalley, D. M., & Goldman, J. (2017). Protein signaling in immune regulation: Implications for disease and therapy. Immunology & Molecular Biology, 18(4), 112–128.

Malgerud, L., Lindberg, J., Wirta, V., Gustafsson-Liljefors, M., Karimi, M., Moro, C. F., Stecker, K., Picker, A., Huelsewig, C., Stein, M., & others. (2017). Molecular mechanisms in pancreatic cancer. Molecular Oncology, 11(10), 1413. https://doi.org/10.1002/1878-0261.12123

 Matsumoto, K., Yamamoto, Y., & Kimura, H. (2022). Advances in peptide therapeutics: Personalized approaches and clinical applications. Journal of Medicinal Chemistry, 65(8), 4789–4805. https://doi.org/10.1021/acs.jmedchem.1c01473

Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021). Trends in peptide drug discovery. Nature Reviews Drug Discovery, 20(4), 309–325. https://doi.org/10.1038/s41573-020-00135-8

Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., ... & Wu, C. J. (2017). An immunogenic personal neoantigen vaccine for melanoma. Nature, 547(7662), 217–221. https://doi.org/10.1038/nature22991

Payne, K., Gavan, S. P., Wright, S. J., & Thompson, A. J. (2018). Genomic medicine: Costs, benefits, and policy implications. Nature Reviews Genetics, 19(4), 235. https://doi.org/10.1038/nrg.2018.10

Personalized Medicine Coalition. (2017). Personalized medicine at the crossroads: The evolution of targeted therapies. Washington, DC: PMC Publications.

  Rashidian, M., Dozier, J. K., & Distefano, M. D. (2013). Enzyme-mediated labeling of proteins: techniques and approaches. Bioconjugate Chemistry, 24(8), 1277–1294. https://doi.org/10.1021/bc400155b

 Roden, D. M., McLeod, H. L., Relling, M. V., Williams, M. S., Mensah, G. A., & Peterson, J. F. (2011). Pharmacogenomics: The genetics of variable drug responses. Circulation, 123(15), 1661–1670. https://doi.org/10.1161/CIRCULATIONAHA.110.914762

Sahin, U., & Türeci, Ö. (2018). Personalized cancer immunotherapy: Targeting the unique genetic makeup of tumors. Nature Reviews Drug Discovery, 17(8), 540–561. https://doi.org/10.1038/nrd.2018.106

  Salgado, R., Moore, H., Martens, J. W. M., Lively, T., Malik, S., McDermott, U., Michiels, S., Moscow, J. A., & Tejpar, S. (2018). Developing new drug biomarkers in oncology. Nature Reviews Drug Discovery, 17(1), 1. https://doi.org/10.1038/nrd.2017.254

Schmid, S., Nakamura, Y., & Narita, Y. (2021). Personalized peptide vaccines: Recent advances in development and clinical applications. Clinical Cancer Research, 27(15), 4140–4150. https://doi.org/10.1158/1078-0432.CCR-21-0285

 Schork, N. J. (2015). Personalized medicine: Time for one-person trials. Nature, 520(7549), 609–611. https://doi.org/10.1038/520609a

 Seyhan, A. A. (2019). Lost in translation: The valley of death across preclinical and clinical divide—identification of problems and overcoming obstacles. Translational Medicine Communications, 4, 18. https://doi.org/10.1186/s41231-019-0050-7

Soda, K., Kano, Y., Chiba, F., Koizumi, K., & Miyaki, Y. (2007). Selective targeting of dysfunctional proteins: The future of peptide-based medicine. Biochimica et Biophysica Acta, 1773(6), 1295–1304.

  Squires, A. M., Charnock, J. M., & Davies, R. J. (2008). Structural insights into the self-assembly and gelation of Fmoc-dipeptides. Langmuir, 24(23), 12107–12114. https://doi.org/10.1021/la801757t

  Sternberg, C. N., & Beltran, H. (2017). Molecular insights and targeted therapies in bladder cancer. Nature Reviews Urology, 14(2), 71. https://doi.org/10.1038/nrurol.2016.273

 Stevens, M. M., George, J. H., & Buriak, J. M. (2016). Exploring and engineering the cell surface interface. Science, 310(5751), 1135–1138. https://doi.org/10.1126/science.1115163

Topol, E. J. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. https://doi.org/10.1038/s41591-018-0300-7

Tsukiji, S., Miyagawa, M., Takaoka, Y., Tamura, T., & Hamachi, I. (2009). Ligand-directed tosyl chemistry for protein labeling in vivo. Nature Chemical Biology, 5(5), 341–343. https://doi.org/10.1038/nchembio.156

U.S. National Library of Medicine. (2018). Advances in peptide therapeutics: Emerging trends in precision medicine. Bethesda, MD: National Institutes of Health.

Verma, S. (2012). Custom-tailored therapeutics: The molecular approach to individualized medicine. Trends in Pharmacological Sciences, 33(1), 45–52.

 Wang, X., Yu, Y., & Deng, C. (2023). Personalized peptide-based treatments: The next frontier in individualized medicine. Journal of Personalized Medicine, 13(2), 187. https://doi.org/10.3390/jpm13020187

Williams, D. A. (2015). Genomic medicine and personalized peptide therapy: Aligning treatment with molecular signatures. Journal of Molecular Therapeutics, 22(3), 198–210.

 Yadav, M., Jhunjhunwala, S., Phung, Q., Lupardus, P., Tanguay, J., Bumbaca, S., ... & Modrusan, Z. (2020). Predicting immunogenic tumor mutations by combining mass spectrometry and exome sequencing. Nature, 545(7652), 112–116. https://doi.org/10.1038/nature22389


View Dimensions


View Plumx


View Altmetric



0
Save
0
Citation
35
View
0
Share

Stay connected